Aldeyra Therapeutics, Inc. Quarterly Debt-to-equity in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Aldeyra Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q3 2014 to Q3 2024.
  • Aldeyra Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 27.9 %, a 35.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 27.9 +7.37 +35.8% Sep 30, 2024
Q2 2024 23.9 +4.13 +20.9% Jun 30, 2024
Q1 2024 21.9 +3.36 +18.1% Mar 31, 2024
Q4 2023 21.5 +4.25 +24.7% Dec 31, 2023
Q3 2023 20.6 +5.02 +32.3% Sep 30, 2023
Q2 2023 19.7 +5.31 +36.8% Jun 30, 2023
Q1 2023 18.5 +5.63 +43.6% Mar 31, 2023
Q4 2022 17.2 +4.63 +36.7% Dec 31, 2022
Q3 2022 15.6 +0.62 +4.15% Sep 30, 2022
Q2 2022 14.4 -3.39 -19% Jun 30, 2022
Q1 2022 12.9 -14.1 -52.2% Mar 31, 2022
Q4 2021 12.6 -23.6 -65.2% Dec 31, 2021
Q3 2021 14.9 -24.9 -62.5% Sep 30, 2021
Q2 2021 17.8 -29.5 -62.4% Jun 30, 2021
Q1 2021 27 -11.2 -29.2% Mar 31, 2021
Q4 2020 36.2 +7.52 +26.2% Dec 31, 2020
Q3 2020 39.8 +21.7 +120% Sep 30, 2020
Q2 2020 47.3 +34.6 +272% Jun 30, 2020
Q1 2020 38.2 +23.9 +167% Mar 31, 2020
Q4 2019 28.7 +13.7 +92% Dec 31, 2019
Q3 2019 18.1 +0.93 +5.43% Sep 30, 2019
Q2 2019 12.7 +0.73 +6.1% Jun 30, 2019
Q1 2019 14.3 +3.38 +31% Mar 31, 2019
Q4 2018 14.9 +4.28 +40.2% Dec 31, 2018
Q3 2018 17.1 +5.76 +50.6% Sep 30, 2018
Q2 2018 12 -1.93 -13.9% Jun 30, 2018
Q1 2018 10.9 -2.41 -18.1% Mar 31, 2018
Q4 2017 10.6 -3.05 -22.3% Dec 31, 2017
Q3 2017 11.4 -1.67 -12.8% Sep 30, 2017
Q2 2017 13.9 +2.08 +17.6% Jun 30, 2017
Q1 2017 13.3 +2.67 +25.1% Mar 31, 2017
Q4 2016 13.7 +3.14 +29.8% Dec 31, 2016
Q3 2016 13 +1.07 +8.94% Sep 30, 2016
Q2 2016 11.8 -3.28 -21.7% Jun 30, 2016
Q1 2016 10.7 -12.1 -53.2% Mar 31, 2016
Q4 2015 10.6 +80 Dec 31, 2015
Q3 2015 12 +34.2 Sep 30, 2015
Q2 2015 15.1 Jun 30, 2015
Q1 2015 22.7 Mar 31, 2015
Q4 2014 -69.4 Dec 31, 2014
Q3 2014 -22.3 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.